Multi-dose injection pens
The current Ozempic pen label separates before-first-use and after-first-use storage
The June 2026 Novo Nordisk Ozempic injection label says an unused single-patient-use multi-dose pen should be refrigerated at 36°F to 46°F (2°C to 8°C), not in the freezer or directly beside the refrigerator cooling element. After first use, the pen may be stored for 56 days either at controlled room temperature from 59°F to 86°F (15°C to 30°C) or refrigerated at 36°F to 46°F. Keep the cap on when the pen is not in use, protect it from excessive heat and sunlight, remove the needle after each use, and store it without a needle attached.
- Use the labeled expiration date only for an unused pen that remained under the required refrigerated conditions; after first use, track the 56-day limit.
- Do not freeze the pen or use it if it has been frozen, even if it later thaws or the solution appears unchanged.
- A multi-dose pen has storage instructions that should not be copied onto a single-dose syringe, tablet bottle, or compounded vial.
Single-dose prefilled syringes
Current Ozempic prefilled syringes have a separate 28-day room-temperature allowance
The current injection label also includes single-dose prefilled syringes. It directs refrigerated storage at 36°F to 46°F (2°C to 8°C). If needed, a syringe may be kept at 46°F to 86°F (8°C to 30°C) for up to 28 days. Keep it in the original carton until administration to protect it from light, never freeze it, and discard the syringe after its single use. This 28-day allowance is not the pen’s 56-day after-first-use rule.
- Confirm that the package actually says single-dose prefilled syringe before applying the 28-day limit.
- Track the date and known temperature range when a syringe leaves refrigerated storage, especially during travel or a delivery delay.
- Ask the pharmacist or manufacturer before using a syringe when the exposure exceeded 86°F, freezing is possible, or the timeline is incomplete.
Ozempic tablets
Ozempic tablets use dry room-temperature storage, not injection refrigeration rules
The current combined Ozempic and Rybelsus tablet label says Ozempic tablets should be stored at 68°F to 77°F (20°C to 25°C), with permitted excursions from 59°F to 86°F (15°C to 30°C). Tablets should stay in the original bottle until use and be kept dry and protected from moisture. Refrigeration, a pill organizer, a bathroom cabinet, a damp travel bag, or transferring tablets to another container can create questions that do not exist for an injection carton. Confirm the exact tablet bottle and ask the pharmacist how to handle an uncertain moisture or temperature exposure.
- Current official labeling includes both Ozempic injection and Ozempic tablets, so the brand name alone does not identify the correct storage directions.
- Keep tablets in the original manufacturer bottle rather than combining them with another medicine or removing the moisture-protective packaging.
- Do not apply the pen’s 56-day rule or the syringe’s 28-day allowance to Ozempic tablets.
Travel, heat, and warm shipments
Package feel alone cannot reconstruct the storage history
A cool ice pack does not prove an injection stayed within range, and a room-temperature carton does not show how long it was warm or whether it froze in transit. For travel or a delayed shipment, document the exact product, package type, departure or delivery time, known temperatures, first-use date for a pen, carton condition, and any contact with frozen packs, direct sun, a vehicle, or a heater. Avoid improvised cooling that could freeze the medicine. The dispensing pharmacy or Novo Nordisk can interpret a specific exposure and explain whether the product should be used, discarded, or replaced.
- Carry the medication in its labeled original packaging with the prescription and pharmacy contact information.
- Do not leave Ozempic in checked luggage, a parked vehicle, direct sunlight, a freezer compartment, or direct contact with ice or frozen gel packs.
- Do not change the schedule, repeat a dose, use another person’s product, or buy a no-prescription replacement because of a storage concern.
Compounded semaglutide boundary
Ozempic storage limits do not automatically apply to compounded semaglutide
Ozempic injection and tablets are FDA-approved finished semaglutide products with manufacturer-specific packages and labels. A patient-specific compounded semaglutide preparation is not FDA-approved Ozempic or a generic Ozempic equivalent. Its route, concentration, inactive ingredients, container, sterility controls, refrigeration directions, beyond-use date, light protection, and excursion guidance may differ by prescription and compounding pharmacy. Follow the exact dispensing label and contact that pharmacy rather than transferring Ozempic’s 56-day, 28-day, or tablet-storage rules.
- Confirm the patient name, pharmacy, active ingredient, route, concentration, additives, beyond-use date, and storage directions before use.
- Do not assume a compounded vial remains usable because an Ozempic pen would still be within 56 days.
- Reject sellers that call compounded semaglutide FDA-approved Ozempic, hide the dispensing pharmacy, omit a patient-specific label, or use one storage rule for every formulation.
When to pause and call
An uncertain storage history is a product-quality question, not a dosing problem
Contact the dispensing pharmacist or manufacturer before using Ozempic when the formulation or presentation is uncertain, required refrigeration cannot be confirmed, the time outside range is unknown, freezing or excessive heat is possible, tablets may have become damp, the carton or bottle is damaged, or the medicine does not match the current appearance instructions. Keep storage suitability separate from missed-dose or glucose-management decisions. A clinician should coordinate any treatment change, especially when Ozempic is being used with insulin, a sulfonylurea, or another diabetes medicine.
- Ask the pharmacy or manufacturer to document whether the exact product is usable, should be discarded, needs replacement, or requires further review.
- Do not compensate for a delayed or discarded product by doubling, changing strength, combining formulations, or transferring medicine between containers.
- Seek urgent help for a suspected medication error or severe symptoms rather than waiting for a routine storage reply.